Alexis N. Lilly

Alexis Lilly protects public entities, institutional investors and individuals through complex litigation targeting corporate negligence and misconduct.

Alexis is a part of the firm’s team that represents dozens of governmental entities, including states, counties, cities, towns, and townships in litigation targeting the alleged deceptive marketing and over-distribution of highly addictive opioid drugs, a contended cause of the nationwide opioid crisis.

A former Motley Rice law clerk, Alexis was the Technical Editor of the American University Business Law Review, Vol. 9, and served as a student attorney for American University Washington College of Law’s Civil Advocacy Clinic in Washington, D.C., while completing her legal studies. She also assisted faculty as a Dean’s fellow for the school’s Legal Rhetoric Department, served as a judicial intern for U.S. District Judge Rudolph Contreras of the U.S. District Court for D.C., and gained valuable experience as a law clerk for the U.S. Attorney’s Office, District of Arizona.

Blog Posts

September 29, 2022

Children say Instagram worsens their mental health Causes, Not Just Cases

by: Previn Warren

July 26, 2022

Nearly $4.25 billion Teva settlement a sign opioid litigation strategy is working to abate the crisis, help communities recover Causes, Not Just Cases

by: Joseph F. Rice

February 25, 2022

Significant opioid relief finally on the way Causes, Not Just Cases

by: Joseph F. Rice

News

February 17, 2026

National Roundup Class Settlement Agreement Reached in Missouri State Court

by: Motley Rice

May 28, 2025

Glyphosate Ban

by: Motley Rice